Position in AXSM
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,343,100
New position
Shares Held
30,000
first reported quarter
Ownership
0.058%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#9
of 94 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Curated Wealth Partners LLC holds $74,910,293 across 22 Biotechnology names. AXSM ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,738 | $22,907,611 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,858 | $21,288,853 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
35,628 | $10,725,096 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
This page
|
30,000 | $7,343,100 | |
| 5 | AVIR |
Atea Pharmaceuticals, Inc.
|
695,000 | $3,231,750 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
35,019 | $3,044,902 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
35,000 | $1,908,900 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
50,000 | $1,204,000 |
All Filings in AXSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,343,100 | 30,000 | Shares | Other | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||